Parallel

CBT digital therapeutic for IBS patients receives FDA De Novo clearance (Updated)
By Dave Muoio | 04:50 pm | December 08, 2020
Mahana Therapeutics' Parallel is a three-month digital treatment that logs patients' symptoms to deliver relevant guidance and teach them condition-management skills.